// App-Quantinova.ai

3807 : Histone deacetylase inhibitors repress hypoxia signaling through affecting Hsp90

Researchers

Presenter

  • Chunzhang Yang

Principal Investigators

  • Zhengping Zhuang

Medical Centers

  • NIAMS, Bethesda, MD.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Hypoxia-inducible factor-1

Drug/Treatment

  • Vorinostat

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A